Temporary housing aimed at easing homelessness set for Downtown Atlanta lot
A nonprofit plans to convert shipping containers once used as temporary hospitals during the Covid-19 pandemic into temporary housing for people experiencing homelessness.
Cameron Mitchell’s Cento in German Village opens for business
Cameron Mitchell Restaurants finally has its German Village destination.
Activist hedge fund Starboard Value buys stake in Tampa’s Bloomin’ Brands
Bloomin' faces a corporate shakeup by the activist investor behind the makeovers of Olive Garden and Papa John's.
Smashburger now open near Ohio State University
A burger brand is now serving up breakfast, lunch, dinner and drinks near Ohio State University.
Lower Broadway to become home of new entertainment complex
Make Ready is set to open sometime this fall.
St. Edward’s University ventures into nursing education
St. Edward's University is diverting from its traditional liberal arts offerings with the launch of a nursing program designed for working professionals. It aims to fill a big hole in the region's workforce.
AI drug discovery company Genesis Therapeutics scores $200 million in new funding
“We founded the company with the straightforward vision of transformative AI technologies for transformative therapies for patients,” said co-founder and CEO Evan Feinberg.
Zivian Health lands $3M to expand digital health platform
The company is working to bring together nurse practitioners, physician assistants and physicians.
Most US nursing homes are understaffed, potentially compromising health care for more than a million elderly residents
More than 80% of U.S. nursing homes reported staffing shortages in early 2023. SciLine interviewed Dr. Jasmine Travers, a gerontological nurse practitioner and assistant professor of nursing at New York University Rory Meyers College of Nursing, and asked her how the shortage affects health care for nursing home residents, if nursing homes in poorer neighborhoods have been hit harder by the shortages, and what can be done to fix the problem.
Below are some highlights from the discussion.…
Fulcrum swings back up after FDA lifts clinical hold
Shares of the Cambridge biotech soared after the U.S. Food and Drug Administration lifted a hold that had paused development of its sickle-cell drug for the last six months.